Article PDF
Use our pre-submission checklist
Avoid common mistakes on your manuscript.
Rights and permissions
About this article
Cite this article
Androgen receptor (AR) activation levels on circulating tumor cells (CTCs) to predict response to second-line therapy in castration-resistant prostate cancer (CRPC). Science-Business eXchange 5, 1168 (2012). https://doi.org/10.1038/scibx.2012.1168
Issue Date:
DOI: https://doi.org/10.1038/scibx.2012.1168